Percheron Therapeutics Limited (ASX:PER)

Percheron Therapeutics Revenue

In the fiscal year ending June 30, 2025, Percheron Therapeutics had annual revenue of 1.80M AUD, down -39.32%. Percheron Therapeutics had revenue of 1.65M in the half year ending June 30, 2025, with 12.09% growth.

• Revenue: 1.80M
• Revenue Growth: -39.32%
• P/S Ratio: 4.83
• Revenue / Employee: 225.13K
• Employees: 8
• Market Cap: 8.70M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.80M	-1.17M	-39.32%
Jun 30, 2024	2.97M	1.00M	51.07%
Jun 30, 2023	1.96M	186.87K	10.51%
Jun 30, 2022	1.78M	1.20M	207.72%
Jun 30, 2021	577.76K	-90.67K	-13.56%